|
Delayed
Nasdaq Stockholm
14:53:49 08/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.700 SEK | 0.00% |
|
-0.58% | -10.53% |
| 09-02 | Enzymatica CEO buys additional shares | FW |
| 09-01 | Enzymatica CEO buys 33 384 shares | FW |
| Market Cap | 413M 369M 344M 312M 588M 39.92B 593M 4.13B 1.61B 20.3B 1.55B 1.52B 65.26B | P/E 2024 |
-5.73x | P/E 2025 | -8.89x |
|---|---|---|---|---|---|
| Enterprise Value | 381M 340M 317M 288M 543M 36.81B 547M 3.81B 1.49B 18.72B 1.43B 1.4B 60.18B | EV / Sales 2024 |
5.88x | EV / Sales 2025 | 7.96x |
| Free-Float |
56.66% | Yield 2024 * |
-
| Yield 2025 | - |
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| ENZY | Delayed | |
Deutsche Boerse AG
| EN9 | Delayed | |
|
Börse Stuttgart
| EN9 | Delayed | |
|
Boerse Muenchen
| EN9 | Real-time |
| 1 week | -0.58% | ||
| Current month | -0.58% | ||
| 1 month | -19.05% | ||
| 3 months | -27.66% | ||
| 6 months | -46.88% | ||
| Current year | -10.53% |
| 1 week | 1.64 |  | 1.79 |
| 1 month | 1.55 | | 2.19 |
| Current year | 1.55 | | 3.4 |
| 1 year | 1.55 | | 3.4 |
| 3 years | 1.34 | | 5.45 |
| 5 years | 1.34 | | 12 |
| 10 years | 1.34 | | 24.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sana Alajmovic
CEO | Chief Executive Officer | - | 01/02/2026 |
Holger Lembrér
DFI | Director of Finance/CFO | - | 13/04/2026 |
| Chief Tech/Sci/R&D Officer | - | 27/08/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 58 | 15/02/2016 | |
Bengt Baron
CHM | Chairman | 64 | 19/12/2016 |
| Director/Board Member | 71 | 19/12/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/17/26 A | Buy | Chief Financial Officer | 50,000 | 0.0206% | ||
| 4/1/26 A | Sell | Responsable ventes & marketing | 40,000 | 0.0165% | ||
| 12/30/25 A | Buy | Chairman | 20,000 | 0.0082% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -0.58% | -19.05% | -56.58% | 41.19M | |
| +2.70% | +2.73% | +40.91% | +110.31% | 1,060B | |
| +1.44% | -2.38% | +36.83% | +63.95% | 623B | |
| +1.75% | +3.73% | +16.55% | +83.05% | 480B | |
| +0.60% | -1.73% | +62.98% | +37.46% | 352B | |
| -1.13% | +1.75% | +21.90% | +41.56% | 345B | |
| -0.94% | +0.51% | +11.42% | +34.64% | 274B | |
| -0.86% | -1.82% | -5.67% | +11.05% | 249B | |
| +2.60% | -2.00% | +39.77% | +54.44% | 223B | |
| +1.82% | -1.48% | +25.75% | +96.48% | 182B | |
| Average | -0.15% | -0.49% | +23.14% | +47.64% | 378.8B | |
| Weighted average by Cap. | -0.17% | +0.04% | +31.48% | +70.23% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 45.58M 40.72M 37.99M 34.51M 64.99M 4.41B 65.48M 457M 178M 2.24B 171M 167M 7.21B | 53.9M 48.16M 44.93M 40.81M 76.87M 5.21B 77.44M 540M 211M 2.65B 202M 198M 8.52B |
| Net income | -53.18M -47.52M -44.33M -40.27M -75.84M -5.14B -76.4M -533M -208M -2.62B -200M -195M -8.41B | -51.89M -46.36M -43.26M -39.29M -74M -5.02B -74.55M -520M -203M -2.55B -195M -191M -8.21B |
| Net Debt | -73.01M -65.24M -60.86M -55.28M -104M -7.06B -105M -731M -286M -3.59B -274M -268M -11.55B | -32.11M -28.69M -26.77M -24.31M -45.79M -3.11B -46.13M -322M -126M -1.58B -121M -118M -5.08B |
Employees
18
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/10/26 | SEK 1.700 | 0.00% | 9,651 |
| 07/10/26 | SEK 1.700 | -1.73% | 20,989 |
| 06/10/26 | SEK 1.730 | -2.81% | 75,633 |
| 05/10/26 | SEK 1.780 | -0.56% | 31,245 |
| 02/10/26 | SEK 1.790 | +3.17% | 24,436 |
Net sales - Rate of surprise
- Stock Market
- Stocks
- ENZY Stock
Select your edition
All financial news and data tailored to specific country editions
